Early Access — free while we kick the tires
EdgarHawk

Katzoff David J

Chief Financial Officer

Officer
1 filing analyzed · 1 company · Latest 2025-03-24

Companies

Company Buys Sells Direction
Alzamend Neuro, Inc. ALZN 1 0 Net buying

Activity

March 2025
2025-03-24 Alzamend Neuro, Inc. ALZN
high
Buy
5,000 shares
$5,048
Significance 7/10

CFO David Katzoff buys 5,000 shares of ALZN at $1.01; 5.5K post-transaction holdings, joining 2 other insiders in cluster buy.

CFO David Katzoff purchased 5,000 shares at $1.01 on 2025-03-21, increasing his holdings by 925.9% from 540 to 5,540 shares. The stock is currently trading at $9.18, down 90.5% from its 52-week high of $96.30, placing his entry point near a significant trough. His cross-ticker track record shows 1 prior buy with an average 90-day return of +41935.7%, and his prior ALZN buy on 2023-09-26 was well-timed at the 90-day mark, suggesting some pattern of accumulation at attractive inflection points. The coincident cluster activity—2 other insiders also bought within the past 14 days—indicates potential coordinated conviction, though the company is unprofitable with a negative net income of $-1,039,434.00. This large relative buy by the CFO warrants tracking to determine whether it reflects confidence in a turnaround or opportunistic accumulation at distressed pricing.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access